Sodium metatungstate (5 mg/kg，腹腔注射，一天一次，从第 0 天至第 4 天、第 7 天至第 11 天、第14 天至第 18 天) 联合抗 CD73 抗体和 AZD4635 (HY-101980) 可降低多发性骨髓瘤 (MM) …

POM 1是一种化学化合物，被称为外源性胞外核苷酸酶（CD39）的强效选择性抑制剂，该酶参与ATP水解为ADP和AMP的过程。 在研究中，POM 1被用于研究嘌呤能信号通路，该通路在各 …

POM 1 is a non-specific inhibitor of NTPDase8 (ecto-nucleoside-triphosphate-diphosphohydrolases) and has been observed to inhibit renal protection activated through …

POM 1, also known as sodium polyoxotungstate and sodium metatungstate, is a novel, potent inhibitor of ecto-nucleoside triphosphate diphosphohydrolases (Ecto-NTPDases). POM 1 …

POM 1 is a polyoxometalate that inhibits ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) 1 and 3 with K i values of 2.58 and 3.26 µM, respectively. 1 It demonstrates 10 …

POM-1 (sodium polyoxotungstate) is a novel NTPDase inhibitor, which has shown promising results with the inhibition of recombinant NTPDases 1, 2 and 3. We have tested the …

POM 1, also known as sodium polyoxotungstate and sodium metatungstate, is a novel, potent inhibitor of ecto-nucleoside triphosphate diphosphohydrolases (Ecto-NTPDases). POM 1 …

POM 1 is an inhibitor of Ecto-NTPDases that displays minor selectivity for NTPDases 1 and 2 over NTPDase 3 and P2Y 12 (K i values are 2.58, 3.26, > 10 and 28.8 μ M for NTPDase 1, …